Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
66 participants
INTERVENTIONAL
2023-12-21
2024-06-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Hypoxia and Kynurenine Pathway in Periodontal Inflammation
NCT07182448
Evaluation of Free Aminoacids in Saliva as A Diagnostic Biomarker of Periodontal Disease
NCT04642716
Trimethylamine N-oxide (TMAO) Levels in Periodontal Disease
NCT06580431
Dietary Supplementation With Low-Dose Omega-3 Reduces Salivary TNF-α Levels in Patients With Chronic Periodontitis
NCT02719587
An Evaluation of Salivary Oxidant and Antioxidant Levels in Peri-implant Health and Disease
NCT05724706
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
DIAGNOSTIC
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Young (25-44 years) with a healthy periodontium
Periodontal Indices
Saliva, serum and periodontal indexes were obtained from patients
young (25-44 years) with Periodontitis
Periodontal Indices
Saliva, serum and periodontal indexes were obtained from patients
Old (≥65 years) with a healthy periodontium
Periodontal Indices
Saliva, serum and periodontal indexes were obtained from patients
Old (≥65 years) with Periodontitis
Periodontal Indices
Saliva, serum and periodontal indexes were obtained from patients
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Periodontal Indices
Saliva, serum and periodontal indexes were obtained from patients
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Exclusion Criteria
* use of antibiotics, anti-inflammatory drugs, immunosuppressants, beta-blockers, calcium channel blockers, or anticoagulants within the last 6 months
* presence of diabetes, rheumatoid arthritis, or other systemic conditions such as cardiovascular, renal, hepatic, and neurodegenerative disorders
* pregnancy or lactation
* alcoholism
* smoking
* nonsurgical periodontal treatment in the past 6 months or surgical treatment in the past 12 months
* having less than 20 natural teeth, excluding third molars
* use of orthodontic appliances
26 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Istanbul Medipol University Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Hadi Sayedyousef
Phd candidate
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Istanbul Medipol University
Istanbul, Unkapani, Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
1078
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.